PlainRecalls
FDA Drug Low Class III Completed

Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.

Reported: August 30, 2023 Initiated: August 14, 2023 #D-1103-2023

Product Description

Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.

Reason for Recall

Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.

Details

Units Affected
13,502 vials
Distribution
Nationwide in the U.S.A.
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.. Recalled by Baxter Healthcare Corporation. Units affected: 13,502 vials.
Why was this product recalled?
Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 30, 2023. Severity: Low. Recall number: D-1103-2023.